Response prediction with HSD3B1
نویسندگان
چکیده
منابع مشابه
Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility.
3beta-hydroxysteroid dehydrogenases (HSD3Bs), encoded by the HSD3B gene family at 1p13, have long been hypothesized to have a major role in prostate cancer susceptibility. The recent reports of a prostate cancer linkage at 1p13 provided additional evidence that HSD3B genes may be prostate cancer susceptibility genes. To evaluate the possible role of HSD3B genes in prostate cancer, we screened a...
متن کاملPrediction of Latent Values with Response / Measurement Error ∗
We develop the predictor of the latent value of a sample subject when there two distinct sources of measurement error: subject specific response error (attributable to inherent variability in a subject’s response) and position-specific measurement error (attributable to position variability in a sample). Data set corresponding to total saturated fat intake for volunteer study subjects in the Se...
متن کاملEarly prediction of blonanserin response in Japanese patients with schizophrenia
BACKGROUND Blonanserin is a second-generation antipsychotic used for the treatment of schizophrenia in Japan and Korea. The present study aimed to examine early prediction of blonanserin in patients with schizophrenia. METHODS An 8-week, prospective, single-arm, flexible-dose clinical trial of blonanserin in patients with schizophrenia was conducted under real-world conditions. The inclusion ...
متن کاملStructured Prediction of Network Response
We introduce the network response problem (Su et al. 2014): given a network G = (V,E) and an action a, predict the subnetworkGa = (Va, Ea) that responses to the action, that is, which nodes v ∈ Va perform the action, and which directed edges e = (v, u) ∈ Ea relay the action from v to an adjacency node u. We assume that G is directed, and any undirected network can be seen as a special case. We ...
متن کاملPrediction of response to optimize outcome of treatment with erythropoietin.
Recombinant human erythropoietin (EPO; epoetin) has been shown to be effective in improving anemia in a proportion of cancer patients. The response rate is approximately 60%, but varies considerably according to baseline hematocrit and transfusion needs, as well as the response criteria used. Response is not greatly influenced by the type of tumor, except in situations of major marrow involveme...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Urology
سال: 2017
ISSN: 1759-4812,1759-4820
DOI: 10.1038/nrurol.2017.192